Endocyte Inc (ECYT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Endocyte Inc (ECYT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7978
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte’s proprietary small molecule drug conjugate (SMDC) technology is used to create novel SMDCs and companion imaging agents for personalized targeted therapies. The company develops therapeutic immunotherapy approach that involves potent immune cells, called chimeric antigen receptor T-cell (CAR T-cell) to fight cancer. It has operations in Indianapolis and West Lafayette. Endocyte is headquartered in West Lafayette, Indiana, the US.

Endocyte Inc (ECYT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Endocyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Endocyte Inc, Medical Devices Deals, 2012 to YTD 2018 10
Endocyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Endocyte Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Kyzeo Imaging Enters into Agreement with Endocyte 12
Endocyte Enters into Agreement Seattle Children’s Research Institute 13
Licensing Agreements 14
Endocyte Receives Rights from Radiomedix 14
Endocyte Enters into Licensing Agreement with ABX 15
Endocyte Enters into Licensing Agreement with Nihon Medi-Physics for Etarfolatide 16
Equity Offering 17
Endocyte Raises USD201.2 Million in Public Offering of Shares 17
Endocyte Raises USD86.3 Million in Public Offering of Shares 18
Endocyte Plans to Raise up to USD150 Million in Public Offering of Securities 19
Endocyte Raises Funds through Private Placement of Shares and Warrants 20
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 21
Endocyte Completes Public Offering Of Shares For US$108.7 Million 22
Acquisition 23
Novartis to Acquire Endocyte 23
Endocyte Inc – Key Competitors 25
Endocyte Inc – Key Employees 26
Endocyte Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Jul 31, 2018: Endocyte provides second quarter 2018 financial results and operational update 28
May 09, 2018: Endocyte Provides First Quarter 2018 Financial Results and Operational Update 30
Nov 06, 2017: Endocyte Reports Third Quarter Financial Results 32
Aug 08, 2017: Endocyte Reports Second Quarter Financial Results and Provides Clinical and Pipeline Update 34
May 10, 2017: Endocyte Reports First Quarter Financial Results and Provides Clinical and Pipeline Update 36
Mar 10, 2017: Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline Update 38
Corporate Communications 40
Mar 15, 2018: Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments 40
Feb 27, 2018: Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors 41
Feb 21, 2017: Endocyte Appoints Michael T. Andriole as Chief Financial Officer 42
Product News 43
10/17/2017: New Potential Treatment for Prostate Cancer Receives Boost 43
09/06/2017: Endocyte Presents Data at the 2017 CAR-TCR Summit Further Demonstrating the Ability to Manage Cytokine Release Syndrome Related to CAR T-Cell Therapy 44
04/16/2018: Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018 45
Clinical Trials 46
Sep 05, 2017: Endocyte Announces Presentation at the European Society for Medical Oncology 46
Jun 02, 2017: Endocyte Announces Clinical Update for EC1169 47
May 26, 2017: Endocyte to Announce Updated Data on clinical-stage asset EC1169 at the 2017 American Society of Clinical Oncology Annual Meeting 48
Other Significant Developments 49
Oct 03, 2018: Endocyte becomes first Purdue startup to reach $1.5B in value 49
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Endocyte Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Endocyte Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Endocyte Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Endocyte Inc, Medical Devices Deals, 2012 to YTD 2018 10
Endocyte Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kyzeo Imaging Enters into Agreement with Endocyte 12
Endocyte Enters into Agreement Seattle Children's Research Institute 13
Endocyte Receives Rights from Radiomedix 14
Endocyte Enters into Licensing Agreement with ABX 15
Endocyte Enters into Licensing Agreement with Nihon Medi-Physics for Etarfolatide 16
Endocyte Raises USD201.2 Million in Public Offering of Shares 17
Endocyte Raises USD86.3 Million in Public Offering of Shares 18
Endocyte Plans to Raise up to USD150 Million in Public Offering of Securities 19
Endocyte Raises Funds through Private Placement of Shares and Warrants 20
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 21
Endocyte Completes Public Offering Of Shares For US$108.7 Million 22
Novartis to Acquire Endocyte 23
Endocyte Inc, Key Competitors 25
Endocyte Inc, Key Employees 26
Endocyte Inc, Other Locations 27

List of Figures
Endocyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Endocyte Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Endocyte Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Endocyte Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Endocyte Inc (ECYT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Energiekontor AG (EKT):企業の財務・戦略的SWOT分析
    Summary Energiekontor AG (Energiekontor) is a renewable energy company that develops and operates offshore wind farms. The company operates in the field of project development and sales, power generation in group-owned wind farms, and operation development services. Its services include construction …
  • FLYHT Aerospace Solutions Ltd.:企業の戦略・SWOT・財務分析
    FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Orion Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Orion Health Inc (Orion) is a healthcare technology company that offers software solutions. The company designs healthcare software for hospitals and health systems. Its products comprise electronic health record, rhapsody integration engine, hospital information system and symphonia messagi …
  • National Bank Of Bahrain Bsc
    National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report Summary National Bank Of Bahrain Bsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Amgen, Inc.:企業のM&A・事業提携・投資動向
    Amgen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amgen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Eickhoff Corporation:企業の戦略・SWOT・財務分析
    Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report Summary Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • XOMA Corp (XOMA):企業の財務・戦略的SWOT分析
    XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Haisco Pharmaceutical Group Co Ltd (002653):製薬・医療:M&Aディール及び事業提携情報
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive sy …
  • Velatia SL:企業の戦略的SWOT分析
    Velatia SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Plant Bioscience Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Plant Bioscience Ltd (PBL) is a technology management company that offers services in plant, food and microbial science. The company provides intellectual property management, patent advisory, licensing and technology transfer services. It offers patient consultation and management services, …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務情報
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Huron Consulting Group Inc:企業のM&A・事業提携・投資動向
    Huron Consulting Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huron Consulting Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Washington University in St Louis-製薬・医療分野:企業M&A・提携分析
    Summary Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range o …
  • Aarti Industries Ltd (AARTIIND):企業の財務・戦略的SWOT分析
    Summary Aarti Industries Ltd (Aarti Industries) is a chemical company that manufactures and markets benzene based basic and intermediate chemicals. It offers chemicals, pharma products and surfactants including rubber chemicals, dyes and pigment intermediates; surfactant intermediates, pharmaceutica …
  • Bridgford Foods Corporation:企業の戦略・SWOT・財務情報
    Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical …
  • SOCO International plc (SIA):企業の財務・戦略的SWOT分析
    Summary SOCO International Plc (SOCO) is an oil and gas company that explores, discovers and produces oil and gas reserves. The company offers appraisal and field development services. It provides training and skills and support local communities. SOCO produces and supplies natural resources. SOCO h …
  • Sunland Group Ltd:企業の戦略・SWOT・財務情報
    Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆